February 16, 2017 09:39 AM EST
News Briefing

Alk­er­mes CEO Pops stays fo­cused on 5461 fil­ing plans; Shkre­li gets booed at Har­vard

Shehla Shakoor

Managing Director

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

RFK Jr. claims place­bo-con­trolled vac­cine tri­als are 'rad­i­cal de­par­ture' from past. Ex­perts dis­agree

US drug­mak­ers in­creas­ing­ly look abroad for clin­i­cal tri­als as con­fi­dence in FDA wa­vers

HHS launch­es $500M uni­ver­sal vac­cine plat­form as RFK Jr. shakes up US vac­cine pol­i­cy

Lil­ly CEO Ricks urges Trump to drop drug tar­iff plan

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times